Ftse Mib
38.463,10
-0,50%
DAX
22.559,20
0,28%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
91.965,30
-2,42%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TFF Pharmaceuticals Inc (TFFP) TFF Pharmaceuticals Inc (TFFP) Notizie

TFFP

TFF Pharmaceuticals (TFFP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TFFP
DataOraFonteTitoloSimboloCompagnia
06/02/202522:05PR Newswire (US)TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC DeregistrationNASDAQ:TFFPTFF Pharmaceuticals Inc
04/02/202522:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
03/02/202522:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
23/12/202412:50Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
11/12/202422:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
20/11/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202422:20Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202422:15GlobeNewswire Inc.TFF Pharmaceuticals Announces It Will Wind Down OperationsNASDAQ:TFFPTFF Pharmaceuticals Inc
26/09/202413:00GlobeNewswire Inc.TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug DeliveryNASDAQ:TFFPTFF Pharmaceuticals Inc
11/09/202413:00GlobeNewswire Inc.TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVIDNASDAQ:TFFPTFF Pharmaceuticals Inc
10/09/202413:00GlobeNewswire Inc.TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal ImmunizationNASDAQ:TFFPTFF Pharmaceuticals Inc
03/09/202414:00GlobeNewswire Inc.TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TFFPTFF Pharmaceuticals Inc
14/08/202422:05GlobeNewswire Inc.TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:TFFPTFF Pharmaceuticals Inc
08/07/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
14/06/202422:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TFFPTFF Pharmaceuticals Inc
17/05/202422:07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
07/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202322:52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
21/11/202322:41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322:10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
17/08/202322:01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202312:00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
27/06/202312:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
23/06/202323:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TFFPTFF Pharmaceuticals Inc
11/05/202322:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/03/202321:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/02/202322:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TFFPTFF Pharmaceuticals Inc
27/12/202215:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
15/12/202223:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TFFP

La tua Cronologia

BIT
LDO
Leonardo
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
FCT
Fincantieri
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
IVG
Iveco Group NV
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
SPM
Saipem
BIT
RACE
Ferrari NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci